Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Margaret, Grisius"'
Autor:
Monisha Billings, DDS, MPH, PhD, Bruce A. Dye, DDS, MPH, Timothy Iafolla, DMD, MPH, Alan N. Baer, MD, Margaret Grisius, DDS, Ilias Alevizos, DMD, PhD
Publikováno v:
EBioMedicine, Vol 12, Iss C, Pp 270-279 (2016)
Background: Xerostomia is a chief complaint of patients with Sjögren's syndrome (SS). However, newer proposals for SS classification remove xerostomia and hyposalivation from the criteria list. Given these developments and the importance of patient-
Externí odkaz:
https://doaj.org/article/bf49d8b316114e449862b2856dba1ce1
Autor:
Robert J. Palmer, Sean L. Cotton, Alexis S. Kokaras, Pamela Gardner, Margaret Grisius, Eileen Pelayo, Blake Warner, Bruce J. Paster, Ilias Alevizos
Publikováno v:
Journal of Oral Microbiology, Vol 11, Iss 1 (2019)
Background: Molecular taxonomic assignments in oral microbial communities have been made using probe-matching approaches, but never compared to those obtained by more readily accepted tree-based approaches. Objective: To compare community composition
Externí odkaz:
https://doaj.org/article/71befce5b4984a2585163fba1cdbe100
Autor:
Blake M. Warner, Eileen Pelayo, Ilias Alevizos, Laura C. Cappelli, Margaret Beach, David E. Kleiner, Christian S. Hinrichs, Josephine Feliciano, Margaret Grisius, James L. Gulley, Arun Rajan, Evan J. Lipson, Ravi A. Madan, Astin Powers, Clint T. Allen, Lauren Long, Alan N. Baer
Publikováno v:
The Oncologist. 24:1259-1269
Background The objective of this study was to characterize the clinicopathologic features of sicca syndrome associated with immune checkpoint inhibitor (ICI) therapy. Subjects, Materials, and Methods Consecutive patients with new or worsening xerosto
Publikováno v:
Oral Diseases. 23:387-394
Introduction Oral candidiasis (OC) is a potential oral complication in Sjogren's syndrome (SS). Some studies indicate that the low stimulated salivary flow and not low unstimulated salivary flow is associated with OC in SS, while others report that t
Autor:
Margaret Grisius, Alan N. Baer, Bruce A. Dye, Timothy Iafolla, Monisha Billings, Ilias Alevizos
Publikováno v:
EBioMedicine, Vol 12, Iss C, Pp 270-279 (2016)
EBioMedicine
EBioMedicine
Background Xerostomia is a chief complaint of patients with Sjögren's syndrome (SS). However, newer proposals for SS classification remove xerostomia and hyposalivation from the criteria list. Given these developments and the importance of patient-c
Autor:
Robert J, Palmer, Sean L, Cotton, Alexis S, Kokaras, Pamela, Gardner, Margaret, Grisius, Eileen, Pelayo, Blake, Warner, Bruce J, Paster, Ilias, Alevizos
Publikováno v:
Journal of Oral Microbiology
Background: Molecular taxonomic assignments in oral microbial communities have been made using probe-matching approaches, but never compared to those obtained by more readily accepted tree-based approaches. Objective: To compare community composition
Autor:
Long Shen, Leyla Teos, Lolita Bebris, David I. Yule, Shyh-Ing Jang, Julian L. Ambrus, Indu S. Ambudkar, Margaret Grisius, Yu Zhang, Ilias Alevizos, William D. Swaim, Ana P. Cotrim, Jon H. Won
Publikováno v:
Scientific Reports
The autoimmune exocrinopathy, Sjögren’s syndrome (SS), is associated with secretory defects in patients, including individuals with mild lymphocytic infiltration and minimal glandular damage. The mechanism(s) underlying the secretory dysfunction i
Publikováno v:
Dental Clinics of North America. 49:309-326
Salivary gland hypofunction and complaints of xerostomia are common in elderly patients, irrespective of their living situation. Medication use is frequently related to dry mouth symptoms and reductions in salivary flow rates. Patients with reduced s
Autor:
Janine A. Smith, Vidya Sankar, Michael T. Brennan, Rose Anne Leakan, Margaret Grisius, Marc R. Kok, Sophie Ligier, Lida Radfar, Philip C. Fox, Albert Kingman, Stanley R. Pillemer
Publikováno v:
Arthritis Care & Research. 51:601-604
Objective To screen for potential efficacy and assess feasibility and safety of dehydroepiandrosterone (DHEA) as a treatment for Sjogren's syndrome (SS). Methods A 24-week randomized, double-blinded, pilot trial of oral DHEA (200 mg/day) versus place
Autor:
Margaret Grisius
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 92:156-162
Xerostomia may result from salivary dysfunction secondary to a variety of conditions, including medications, autoimmune disease, and tumoricidal therapy. As the geriatric population increases, the incidence of xerostomia will increase and the oral ma